Primary Cutaneous Non-Hodgkin Lymphoma — Trials

Primary Cutaneous Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

352 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 67
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Mayo Clinic
Termination share: 38.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (77)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05781386	A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors	unknown	Phase 1	255	Jiangsu Simcere Biologics Co., LtdINDUSTRY	1	Sep 21, 2023	clinicaltrials
NCT06037239	Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study	unknown	Phase 1 / Phase 2	53	Peking Union Medical College HospitalOTHER	1	Sep 14, 2023	clinicaltrials